dermatology

News

Innovent gets OK for China's first home-grown IL-23p19 drug

Innovent has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for moderate-to-severe plaque psoriasis.

News

Sanofi slumps despite positive eczema drug readout

Shares in Sanofi have fallen after it reported data from a phase 3 trial of atopic dermatitis drug amlitelimab – even though it met all objectives.

News

LEO bulks up with deal for Boehringer skin drug

LEO Pharma has licensed a medicine for a rare form of psoriasis from Boehringer Ingelheim, plugging a gap in its near-term product portfolio.

News

Nektar eyes pivotal trials for eczema drug cast off by Lilly

Nektar Therapeutics has said phase 2b results show it was right to keep faith with rezpegaldesleukin as a therapy for atopic dermatitis.

News

Dupixent is first FDA-approved drug for rare skin disease

The long list of therapeutic uses for Sanofi and Regeneron's Dupixent has been lengthened by an FDA approval for rare skin disease bullous pemphigoid.

News

Guidance creates access gap in UK for GPP drug Spevigo

People in England and Wales with severe skin disease GPP will soon be able to access a new therapy currently denied to patients in Scotland.

Innovent gets OK for China's first home-grown IL-23p19 drug

Sanofi slumps despite positive eczema drug readout

LEO bulks up with deal for Boehringer skin drug

Nektar eyes pivotal trials for eczema drug cast off by Lilly

Dupixent is first FDA-approved drug for rare skin disease

Guidance creates access gap in UK for GPP drug Spevigo

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

dermatology

Editor's Picks